Assay Development

SAMDI Tech offers a suite of orthogonal assay methodologies to augment drug discovery. Our approach includes label-free and beyond label-free assay development to deliver more data faster while maintaining high-throughput screening capabilities across all technologies.

We offer better, faster assays for diverse analytes such as small molecules, peptides, oligonucleotides, lipids, proteins and antibodies, and we provide assay development solutions, including:

• Elucidating reaction mechanisms
• Affinity selection mass spectrometry (ASMS)
• Characterizing virtually any enzyme activity, including (but not limited to):
  • Acetyltransferases
  • Acyltransferases
  • Arginase
  • Deacetylases
  • Deiminases/Deaminases
  • Demethylases
  • Deubiquitinases
  • Glycosidases
  • Glycosyltransferases
  • Kinases
  • Ligases
  • Methyltransferases
  • Phosphatases
  • Polymerases
  • Proteases
  • RNA and DNA modifying and processing enzymes
  • Ubiquitin ligases
  • And more
• Defining kinetic parameters
• Developing assays for high-throughput screening